Treatment package time in node-positive cutaneous head and neck squamous cell carcinoma.
Treatment package time (TPT) prolongation is associated with lower overall survival (OS) and locoregional control in mucosal head and neck SCC (mHNSCC) but there are few reports in cutaneous HNSCC (cHNSCC). We sought to test the effect of TPT in a cohort of patients with cHNSCC. This is a single institution retrospective study of node-positive cHNSCC patients involving either the parotid and/or cervical nodes treated with curative intent surgery with macroscopic tumor clearance followed by standard fractionation post-operative radiation therapy (PORT) from 2001 to 2014. We assessed the effect of TPT and other prognostic variables on overall survival (OS), SCC specific survival (CSS) progression free survival (PFS) and freedom from locoregional failure (FFLRF). 152 patients met the inclusion criteria for the study. The 5 year OS, CSS, PFS and FFLRF were 62% (95% CI 54-71), 78% (95% CI 71-87), 54% (95% CI 46-64) and 76% (95% CI 68-85) respectively. In a multivariable model, TPT ≥14 weeks was associated with worse outcomes in all endpoints (OS [HR 4.93, 95% CI 2.54-9.56, p<0.001], CSS [HR 6.09, 95% CI 2.33-15.92, p=0.001], PFS [HR 4.29, 95% CI 2.21-8.34, p<0.001] and FFLRF [HR 4.63, 95% CI 1.71-12.51, p=0.007]). Immunosuppression and the presence of ≥2 pathologically involved lymph nodes were also significant adverse factors for both OS and FFLRF; while extracapsular extension (ECE) was also associated with lower FFRLF. Delays to commencing PORT rather than treatment breaks accounted for the majority of cases with prolonged TPT. Prolongation of TPT to 14 weeks or longer may confer a lower probability of locoregional control and survival in patients with lymph node-positive cHNSCC treated with surgery and PORT. Timely referral and commencement of PORT is necessary to maximize long-term disease outcomes.